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Summary The properties of specific prostaglandin 12 (prostacyclin, PG12) binding sites in normal thyroid tissue have been characterised. Tissue samples obtained intraoperatively from patients with 'cold' solitary thyroid nodules (as preoperatively selected by thyroid gland scintigraphy, thyroid gland ultrasonography and Papanicolaou cytology following fine needle aspiration of the nodule area) have been used for thyroid membrane preparation. Employing [3H]iloprost, a chemically stable PG12-analogue as a radioligand, saturation experiments for comparative binding studies have been attempted. Scatchard analysis of the binding data obtained for normal thyroid parenchyma distant to the nodule area revealed heterogeneity of the [3H]iloprost sites exhibiting a high-affinity binding capacity (Bmax) of 613.2+130.4fmolmg-1 membrane protein and a low-affinity binding capacity of 5.1+1.6 pmol mg-1 membrane protein. The equilibrium dissociation constant (Kd) amounted to 18.9+8.9nM and to 131.5+39.2nM, respectively. Scatchard analysis of the binding data obtained for benign thyroid adenoma indicated significant lower binding capacities exhibiting a Bmax of 325.8 + 110.0 fmol mg-1 membrane protein (Kd: 31.0 + 7.5 nM) for the high-affinity sites and of 3.9 + 2.5 pmol mg-1 membrane protein (Kd: 364.9 + 183.6) for the low affinity sites. In cancer tissue a selective loss of the low affinity sites and a significant diminution of the high-affinity sites was observed: in well differentiated cancer the high-affinity sites showed a Bmax of 299.7+46.0fmolmg-1 membrane protein (Kd: 38.9 + 7.3 nM), in anaplastic cancer, less differentiated papillar and follicular cancers The metabolism of cAMP and prostaglandins is altered in a great many cancers. Prostaglandins are associated with the activation of the adenylate cyclase-cAMP-system through specifically membrane bound receptors that have been demonstrated in several tissue fractions or at cell surface membranes (e.g., Hall & Strange, 1984 , Riicker & Schr6r, 1983 Virgolini, 1987) . Increased response to prostaglandins by measuring the cAMP content in neoplastic tissue has been observed in various studies (e.g., Bronsted et al., 1978; Chayoth et al., 1973) , thus prostaglandins are proposed to take part in cellular growth (Feher & Gridali, 1974; Hial et al., 1976) . For thyroid cancer the effects of prostaglandins and of their synthesis inhibitors aspirin or indomethacine have been rarely reported in the literature (Sand et al., 1976) , although an alteration in adenylate cyclase activity has been indicated in thyroid cancers (De Rubertis et al., 1972; Orgiazzi et al., 1977) .
The present study investigated the binding of prostaglandin 12 (PGI2, Moncada et al., 1976) Table I .
The histologically verified fresh thyroid tissue was used for the receptor study within half an hour of removal.
Preparation of human thyroid membrane fraction About 1 g (wet weight) thyroid tissue (normofollicular, adenoma or cancer tissue) was used for the membrane preparation. The method used was a modification described and verified previously (Kowalsky et al., 1972; Moore & Wolff, 1973 (Neumann, 1988 as a thyroid nodule. 'Cold nodules' are a clinical concern due to the risk of malignancy frequently requiring surgical excision (Kendall & Condon, 1969; Perlmutter et al., 1954; Van Herle et al., 1982) .
The demonstration of prostaglandins in the thyroid gland is consistent with the suggestion that they exert an important direct role on the gland (Haye et al., 1973; Friedman et al., 1976; Boenynaemes et al., 1980; Takasu et al., 1981) . PGI2 (Kasai et al., 1986) like the prostaglandins of the E series (Kovalsky et al., 1972; Takasu et al., 1976; Shenkman et al., 1974) are known to stimulate intracellular thyroid processes through interaction with specifically surface membranebound receptors (Brown & Wolff, 1973; Virgolini, 1987) . At present PGI2 is considered to be an important regulator of cell metabolism in various tissues (Moncada & Vane, 1984) . Takasu et al. (1981) first suggested that PGI2 also has an important role in thyroid cell function. However, a major problem in studying PGI2 is its instability in aqueous medium at pH 7.4 because of rapid hydrolysis into the biologically inactive degradation product of 6-oxo-PGF,, (Moncada et al., 1976) . Iloprost was found to be equivalent to PGI2 (Skuballa & Vorbriiggen, 1983) (Riucker & Schr6r, 1983) or rat gastric mucosa (Beinborn et al., 1985) . 'process' may onset at the low affinity sites. Recently similar results were obtained at the PGE1-receptor level in human hepatocellular cancer (Virgolini et al., 1988) . The degree of differentiation of a tumour ranging from poorly to well differentiated, often provides a clue to prognosis or a guide to treatment. As might be expected, the less differentiated the tumour the more aggressive its behaviour and the poorer the prognosis. Kerr et al. (1986) demonstrated a significant influence of histological type, TNM status and age on the survival rate of patients with thyroid cancer. In the present study the decrease of the Bmax and the increase of the Kd of the high affinity binding sites correlate with the histological and cytological diagnosis of the tumour and TNM classification. As hormone sensitive cancers contain receptors, the measurement of receptor levels in surgically removed tumours might be of prognostic and therapeutic value. However, little is known about the effects of the prostaglandins on thyroid gland in the malignant state. Thus, further investigations are necessary to elucidate the role of PGI2 during thyroid carcinogenesis.
Prof. K. Keminger (Dept. of Surgery, Elisabeth Hospital) kindly provided the surgical material and Dr Edith Schmalzer (Dept. of Pathology, Kaiserin-Elisabeth Hospital) the histological diagnosis.
